Biostar Pharmaceuticals IncBSPM 22.52% shares climbed 20.8 percent to $4.50 on volume. Biostar Pharmaceuticals shares have dropped 29.89 percent over the past 52 weeks, while the S&P 500 index has increased 4.57 percent in the same period.
Netflix, Inc.NFLX 19.73% shares surged 19 percent to $118.77 as the company reported better-than-expected earnings for its third quarter and issued a strong outlook for the fourth quarter. Total U.S. streaming members hit 47.5 million, and international streaming members, 39.2 million.
Resources Connection, Inc.RECN 12.56% shares jumped 12.6 percent to $14.70 as the company reported the commencement of a modified Dutch auction tender offer for up to 6 million shares in a $13.50 to $16 per share range.
Merrimack Pharmaceuticals IncMACK 2.04% shares rose 3.7 percent to $5.08. Shire disclosed that it has been granted the EU Marketing Authorization of Onivyde in Combination with 5-fluorouracil and leucovorin for the treatment of metastatic adenocarcinoma of the pancreas in adult patients who have progressed following gemcitabine-based therapy.